COVID-19 Update: We remain open and ready to help. Read More
May 21, 2014, Lincoln, NE: The new Odyssey® Blocking Buffer (TBS) from LI‑COR offers a tested, experiment-ready option for reproducible near-infrared Western blots. It is suitable for use with a wide range of targets for Western blot detection. This new TBS-based blocking buffer is the latest addition to LI‑COR's already popular Odyssey PBS Blocking Buffer product line.
"We now offer researchers a TBS-based solution for the best chance of success with a broad range of targets," says Shawn Mischnick, LI‑COR technical product specialist. "This Odyssey Blocking Buffer is ideal for primary antibodies that are optimized for TBS-based buffer systems."
Odyssey Blocking Buffer (TBS) is ideal for detection of phosphorylated targets and is compatible with most primary antibody protocols that utilize a TBS-based buffering system.
To learn more about this new blocking buffer, click here.